Dr. Deborah Birx appointed as the White House Coronavirus Response Coordinator

The BC Centre for Excellence in HIV/AIDS (BC-CfE) congratulates Dr. Deborah Birx on her appointment as the White House Coronavirus Response Coordinator. Dr. Birx is a longstanding friend and colleague of the BC-CfE. She has spent several decades working on HIV/AIDS immunology, vaccine research and global health and Dr. Birx has provided unparalleled leadership to the President’s Emergency Plan for AIDS Relief (PEPFAR) program.

HIV/AIDS continues to be one of the most destructive global pandemics in history with nearly 38 million people living with the virus as of 2018. The insights gathered from the response to HIV/AIDS will help guide the plan to contain this new viral threat.

Share the Post:
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below